Literature DB >> 24630579

[Infection by human cytomegalovirus].

Sara Sanbonmatsu Gámez1, Mercedes Pérez Ruiz1, José María Navarro Marí2.   

Abstract

Prevalence of human cytomegalovirus infection is very high worldwide. Following primary infection, the virus remains latent, being able to cause recurrences either by reinfection with a new strain or by reactivation of the replication of the latent virus. The most severe disease is seen in congenital infection and in immunosuppressed patients, in whom the virus act as an opportunistic pathogen. Serological techniques are the methods of choice in primary infection and to determine the immune status against CMV in organ donor and receptor. Although well-standardized studies are lacking, the recent commercial availability of methods that measure cellular immune response are promising to predict the risk of CMV disease in immunosuppressed individuals. Molecular assays, that have gradually been substituting viral culture and/or antigen detection, are the most widely used methods for the diagnosis and control of CMV infection.
Copyright © 2014 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  ADNemia; Antigenemia; Citomegalovirus; Cultivo; Culture; Cytomegalovirus; DNAemia; Diagnóstico; Laboratory diagnosis; PCR; Serology, PCR; Serología

Mesh:

Year:  2014        PMID: 24630579     DOI: 10.1016/S0213-005X(14)70145-4

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  2 in total

1.  Epidemiology and biology of a herpesvirus in rabies endemic vampire bat populations.

Authors:  Megan E Griffiths; Laura M Bergner; Alice Broos; Diana K Meza; Ana da Silva Filipe; Andrew Davison; Carlos Tello; Daniel J Becker; Daniel G Streicker
Journal:  Nat Commun       Date:  2020-11-23       Impact factor: 14.919

2.  Relevant pericardial effusion caused by cytomegalovirus infection in an immunocompetent patient: a case report.

Authors:  Tabea Hutter; Dirk Springe; Lukas Ebnöther; Marcos Delgado
Journal:  J Med Case Rep       Date:  2018-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.